L855-0105 Screening compound: N-(2,4-difluorophenyl)-1-methyl-3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxamide

L855-0105 Screening compound: N-(2,4-difluorophenyl)-1-methyl-3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxamide
L855-0105 Screening compound: N-(2,4-difluorophenyl)-1-methyl-3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L855-0105
N-(2,4-difluorophenyl)-1-methyl-3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L855-0105

Molecular Formula

C23H20F2N6O2 (C23 H20 F2 N6 O2)

Compound Name

N-(2,4-difluorophenyl)-1-methyl-3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridine-5-carboxamide

IUPAC name

N-(24-difluorophenyl)-1-methyl-3-[5-(4-methylphenyl)-134-oxadiazol-2-yl]-1H4H5H6H7H-pyrazolo[43-c]pyridine-5-carboxamide

SMILES

Cc(cc1)ccc1-c1nnc(-c2nn(C)c(CC3)c2CN3C(Nc(ccc(F)c2)c2F)=O)o1

InChI

InChI=1S/C23H20F2N6O2/c1-13-3-5-14(6-4-13)21-27-28-22(33-21)20-16-12-31(10-9-19(16)30(2)29-20)23(32)26-18-8-7-15(24)11-17(18)25/h3-8,11H,9-10,12H2,1-2H3,(H,26,32)

InChI Key

GHBAGFNANGQVPM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27480656

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

450.45

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.427

Distribution Coefficient, logD

3.427

Water Solubility, LogSw

-3.76

Polar Surface Area

69.933

Acid Dissociation Constant (pKa)

10.38

Base Dissociation Constant (pKb)

-0.52

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.74

L855-0105 in Drug Discovery

Included in Screening Libraries

Cysteine Proteases Inhibitors Library (7839 compounds)

Hsp90-Targeted Library (11355 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Proteases
  • Kinases

References: we are preparing a list of scientific research reports with L855-0105 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L855-0105?
Check Price and Availability of L855-0105, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L855-0105 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L855-0105
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L855-0105
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L855-0105 available by request